Patent · US Active

Imidazopyridazine compounds

US9169259B2 · kind B2 · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2012
Grant dateOct 27, 2015
Priority date
Expiry dateJan 30, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of novel compounds of formula I:wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.